Tg Therapeutics Income Statement (2010-2026) | TGTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.02B	0.17B	0.04B	0.06B	0.07B	0.08B	0.11B	0.12B	0.14B	0.16B	0.19B	0.20B
Cost of Revenue (Quarter)						0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.03B	0.04B	0.03B
Gross Profit (Quarter)						0.00B	0.00B	0.01B	0.01B	0.16B	0.04B	0.06B	0.07B	0.07B	0.09B	0.11B	0.12B	0.13B	0.15B	0.17B
Operating items
Research & Development (Quarter)	0.04B	0.05B	0.06B	0.05B	0.03B	0.02B	0.02B	0.02B	0.03B	0.01B	0.02B	0.03B	0.02B	0.02B	0.02B	0.05B	0.03B	0.04B	0.04B	0.04B
Selling, General & Administrative (Quarter)	0.03B	0.03B	0.03B	0.02B	0.01B	0.01B	0.05B	0.03B	0.03B	0.03B	0.03B	0.03B	0.04B	0.04B	0.04B	0.05B	0.06B	0.06B	0.06B	0.09B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	0.01B	0.00B	0.01B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.03B	0.04B	0.04B
Operating Expenses (Quarter)	0.08B	0.09B	0.10B	0.07B	0.04B	0.04B	0.08B	0.04B	0.06B	0.05B	0.06B	0.07B	0.06B	0.07B	0.08B	0.11B	0.11B	0.13B	0.14B	0.17B
Operating Income (Quarter)	-0.08B	-0.09B	-0.09B	-0.07B	-0.04B	-0.03B	-0.08B	-0.04B	-0.04B	0.11B	-0.01B	-0.01B	0.01B	0.01B	0.03B	0.01B	0.03B	0.03B	0.05B	0.03B
EBIT (Quarter)	-0.08B	-0.09B	-0.09B	-0.07B	-0.04B	-0.03B	-0.08B	-0.04B	-0.04B	0.11B	-0.01B	-0.01B	0.01B	0.01B	0.03B	0.01B	0.03B	0.03B	0.05B	0.03B
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)						0.00B	0.00B	0.00B	0.00B	0.00B	-0.01B	0.00B	0.00B	0.00B	-0.00B		0.00B	0.00B	-0.02B	0.00B
Non Operating Income (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Net income details
EBT (Quarter)	-0.08B	-0.10B	-0.10B	-0.08B	-0.06B	-0.04B	-0.08B	-0.04B	-0.05B	0.11B	-0.01B	-0.01B	0.01B	0.00B	0.03B	0.01B	0.03B	0.03B	0.05B	0.02B
Tax Provisions (Quarter)											-0.00B	0.00B	-0.00B	0.00B	-0.01B	0.00B	0.00B	-0.36B	0.02B	0.00B
Profit After Tax (Quarter)	-0.08B	-0.09B	-0.09B	-0.07B	-0.04B	-0.04B	-0.08B	-0.04B	-0.05B	0.11B	-0.01B	-0.01B	0.01B	0.00B	0.02B	0.01B	0.03B	0.39B	0.02B	0.02B
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-0.08B	-0.10B	-0.10B	-0.08B	-0.06B	-0.04B	-0.08B	-0.04B	-0.05B	0.11B	-0.01B	-0.01B	0.01B	0.00B	0.03B	0.01B	0.03B	0.39B	0.02B	0.02B
Consolidated Net Income (Quarter)	-0.08B	-0.10B	-0.10B	-0.08B	-0.06B	-0.04B	-0.08B	-0.04B	-0.05B	0.11B	-0.01B	-0.01B	0.01B	0.00B	0.03B	0.01B	0.03B	0.39B	0.02B	0.02B
Income towards Parent Company (Quarter)	-0.08B	-0.10B	-0.10B	-0.08B	-0.06B	-0.04B	-0.08B	-0.04B	-0.05B	0.11B	-0.01B	-0.01B	0.01B	0.00B	0.03B	0.01B	0.03B	0.39B	0.02B	0.02B
Net Income towards Common Stockholders (Quarter)	-0.08B	-0.10B	-0.10B	-0.08B	-0.06B	-0.04B	-0.08B	-0.04B	-0.05B	0.11B	-0.01B	-0.01B	0.01B	0.00B	0.03B	0.01B	0.03B	0.39B	0.02B	0.02B
Additional items
EPS (Basic) (Quarter)	-0.64	-0.78	-0.73	-0.56	-0.42	-0.30	-0.62	-0.28	-0.34	0.80	-0.09	-0.07	0.05	0.03	0.22	0.03	0.19	2.69	0.16	0.14
EPS (Diluted) (Quarter)	-0.64	-0.78	-0.73	-0.56	-0.42	-0.30	-0.62	-0.28	-0.34	0.73	-0.09	-0.07	0.04	0.02	0.20	0.03	0.17	2.43	0.15	0.12
Shares Outstanding (Quarter)	0.13B	0.13B	0.13B	0.13B	0.13B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.15B	0.14B	0.15B	0.15B	0.15B	0.15B	0.15B	0.14B	0.14B
Shares Outstanding (Diluted) (Quarter)	0.13B	0.13B	0.13B	0.13B	0.13B	0.14B	0.14B	0.14B	0.14B	0.16B	0.15B	0.15B	0.16B	0.16B	0.16B	0.16B	0.16B	0.16B	0.16B	0.16B
Shares Outstanding (Entity) (Quarter)	0.14B	0.14B	0.14B	0.14B	0.15B	0.15B	0.15B	0.15B	0.15B	0.15B	0.15B	0.15B	0.15B	0.16B	0.16B	0.16B	0.16B	0.16B	0.16B	0.16B
EBITDA (Quarter)	-0.08B	-0.09B	-0.09B	-0.07B	-0.04B	-0.03B	-0.08B	-0.04B	-0.04B	0.11B	-0.01B	-0.01B	0.01B	0.01B	0.03B	0.01B	0.03B	0.03B	0.05B	0.03B
Interest Expenses (Quarter)	0.01B	0.02B	0.00B	0.01B	0.02B	0.01B	0.01B	0.00B	0.00B	0.01B	-0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Tax Rate (Quarter)											4.99%	-0.27%	-4.58%	9.37%	-19.21%	7.32%	8.84%	-1,408.72%	48.44%	2.95%

Research Tools

Developers

Tg Therapeutics Income Statement (2010-2026) | TGTX

Research Tools

Developers

Tg Therapeutics Income Statement (2010-2026) | TGTX

Create an account

Sign In

Reset Password